Rezultate cautare
1st Prize CSR Internal Campaigns and Mention for Employee Support
Awarded at the CSR Awards Gala 2019
Trophy 1st Place Industry Very large enterprises
Granted by the Chamber of Commerce and Industry of Romania
Trophy 1st Place Industry Very large enterprises
Granted by the Chamber of Commerce and Industry of Romania
Centenial ExcelenceTrophy
The largest Romanian exporter of pharmaceutical products with domestic capital Awarded at the A...
Revocari in structura consiliului
2021
H1 2021 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on July 30, 202...
2023
Q3 2023 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on November 21,...
Diploma of Excellence Note 10 VEKTOR 2020
Excellent communication in Investor Relationship in a ranking made by the Association for Invest...
“Savior Hero ” 2019
Distinction granted by the National Institute of Transfusion Hematology Bucharest for the 1...
Jubilee Trophy of Excellence for 5 years world leader for Nistatin product
Distinction granted by the National Association of Exporters and Importers of Romania (ANEIR)
1st place category Industry – very big companies – pharmaceuticals
Published by the Iasi Chamber of Commerce
Transaction 21.06.2019
Tranzactii persoane initiate 21.06.2019
1st place National Top of Companies
Published by the Chamber of Commerce and Industry of Romania
2022
- 2022 - Q3 2022 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on No...
2020
Q3 2020 Presentation for investors Q3 2020 H1 2020 Teleconference ANTIBIOTICE ...
Diploma of excellence for ranking on the local podium for 10 years in a row
Distinction granted by the Chamber of Commerce and Industry Iasi
2019
- 2019 - Q3 2019 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on...
2018
- 2018 - H1 2018 Meeting with the company's shareholders, investors and analysts - 09.27...
2017
- 2017 - Q3 2017 Meeting with the Company's analysts and investors - 10/19/2017, 10 o'cl...
Transaction 27.01.2017
2019
2024
2024 H1 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on August 20, ...
Antibiotice Iasi – 10 at VEKTOR
The evaluation made by ARIR for excellent communication with investors.
Antibiotice Iasi – 10 at VEKTOR
10 for the quality of communication with investors.
Antibiotice Iasi awarded at the Sustainable Companies Gala in Romania
Prizes for campaigns carried out in 2022: “Solidarity without borders” (prize III-category Inter...
Antibiotice, the most attractive employer in the Romanian pharmaceutical industry
The award for the most attractive employer in the Romanian pharmaceutical industry, according to...
Antibiotice Iasi, the first place for the best company in communicating with investors in 2023
Antibiotice obtained the first place in a row for “The best company in terms of activity in rela...
Antibiotice Iasi awarded with Gold within the most important sustainability ranking in Romania
Antibiotice obtained Gold Level Recognition with 90 points (out of the maximum of 100) in Romani...
2018
First Place in the Ranking of the Most Competitive Romanian Companies
by awarding the National Award 1st place in the category Industry - Very large enterprises - Man...
2023
Antibiotice – a Made in Romania company, awarded by BVB
Made in Romania the 5th edition
Laureate Trophy in the Top Companies from Iasi
Diploma pentru Locul 1 în ierarhia firmelor ieșene, domeniul Industrie – Întreprinderi foarte ma...
The best company in communication with Investors
The award was granted by the Romanian Stock Exchange Investor Relations Association (ARIR)
Antibiotice at the top of the sustainability performance assessment
Antibiotice Iași is in the top 5 in the pharmaceutical sub-industry out of a total of 442 compan...
2017
GOLD in the Romania Corporate Sustainability & Transparency Index 2021
ranking with the 2020 sustainability report
2023
2016
2015
2019
2018
2021
2017
First place, County Top of Companies, Chamber of Commerce, Industry and Agriculture Iasi, 1994
First place, County Top of Companies, Chamber of Commerce, Industry and Agriculture Iasi, 19 ...
First position, County Top of Companies, Chamber of Commerce and Industry 1997
First position, County Top of Companies, Chamber of Commerce and Industry 1997
Diploma of excellence, Chamber of Commerce and Industry 1999
Diploma of excellence, Chamber of Commerce and Industry 1999
Diploma for excellence, Rommedica, 2001
Diploma for excellence, Rommedica, 2001
Certificate of appreciation, Rommedica, 2002
Certificate of appreciation, Rommedica, 2002
Trophy awarded for Top Iasi Companies, Chamber of Commerce and Industry Iasi 2006
Trophy awarded for Top Iasi Companies, Chamber of Commerce and Industry Iasi 2006
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi 2007
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi 2007 ...
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi, 2008
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi, 2008...
Diploma of excellence, Chamber of Commerce and Industry Iasi 2009
Diploma of excellence, Chamber of Commerce and Industry Iasi 2009
2016
Diploma of Honor, 2009
Diploma of Honor, The most dynamic company in the field of export of medicinal products ANEIR, 2...
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi 2010
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi 2010 ...
Laureate – Top of Companies in Iasi and Trophy of Excellence, Chamber of Commerce and Industry Iasi, 2011
Laureate – Top of Companies in Iasi and Trophy of Excellence, Chamber of Commerce and Industry I...
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi, 2011
First place in the hierarchy of companies from Iasi, Chamber of Commerce and Industry Iasi, 2011...
ANEIR Trophy, 2012
ANEIR Trophy, 2012
National Award- National Top of Companies, Chamber of Commerce and industry of Romania, 2012
National Award- National Top of Companies, Chamber of Commerce and industry of Romania, 2012 ...
Chamber of Commerce and Industry, 2013
National Prize, Large enterprises, manufacture of basic pharmaceutical products, Chamber of Comm...
Laureate – Top of Companies in Iasi, Chamber of Commerce and Industry Iasi, 2013
Laureate – Top of Companies in Iasi, Chamber of Commerce and Industry Iasi, 2013
Award of Excellence, Medical Manager Gala, 2013
Award of Excellence, Medical Manager Gala, 2013
Order “Industrial and Commercial Merit” in the rank of Commander 2013
Order "Industrial and Commercial Merit" in the rank of Commander, awarded by President of Romani...
2024
Capital Awards Gala 2015
Second Prize for “Best company in the industry “, Capital Awards Gala 2015
Euroinvent 2015
Euroinvent 2015 - the prize for medicine
USP Certificate
USP Certificate
Diploma and Excelency Trophy
Awarded by Romanian Chamber of Commerce
2015
Reference Standard for Nystatin
USP Standard Reference Traceability for Nystatin Diploma and Trophy
2022
2022
2021
2020
Strongest in Romania
Strongest in Romania 2016
Business excelence
Evolution in the past 12 months
2020
2024
2023
2023 The European Investment Bank (EIB) and Antibiotice have joined forces to develop local med...
O.G.S.M. 12/13.09.2024
Bucharest Dealership, 50 Anastasie Panu Street, Sector 3, Bucharest, Romania
2023
Cessation of dividend payment financial year 2020
Increasing results in the first semester of 2024, in accordance with the business plan “The Future Together”
2022
Amoxiplus® 500 mg/125 mg, film-coated tablets
2023 Dividend payment
2024
2022
2022 In the context of the war crisis in Ukraine, Antibiotice manufactures for the entire popul...
Antibiotice Headquarters, 1 Valea Lupului Street, Iasi 707410, Romania, RO1973096, J22/285/1991
Presentation of the 2023 Preliminary Annual Financial Results
Increasing results in accordance with the business plan “The Future Together” for Antibiotice Iași in the first semester of 2024
Antibiotice SA (symbol ATB) submitted to the Bucharest Stock Exchange, on August 14, the Adminis...
RemiFLU® granules for oral solution in sachet
2023
2021
2021 Antibiotice establishes a vaccination centre within its Research and Development Centre, w...
OGSM 01.07.2024
2020
2020 In the context of the COVID-19 pandemic, Antibiotice supports the Romanian healthcare syst...
Availability of the Integrated Annual Report 2023
We invest responsibly for the health of future generations – Integrated Annual Report 2023
Avertizori in Interes Public
Ioan NANI
2021
Notice of availability H1 Report 2024
The General Meeting of Shareholders to approve the financial results – 2023
Ranolazina Atb® 500 mg, prolonged-release tablets
O.G.S.M. 28.05.2024
Ranolazina Atb® 750 mg, prolonged-release tablets
Antibiotice 500 mg
Governance documents
Notice of availability 2024 Q1 Report
Presentation of the Yearly Report – 2023
2022
Ionut-Sebastian IAVOR
Antibiotice Iasi invests in digitalization
Antibiotice Iasi invests in digitalization for the transition to a sustainable business
The digital transformation of Antibiotice Iasi moves to a new level, by collaborating with IBM...
Ranolazina Atb® 375 mg, prolonged-release tablets
Mihai TRIFU
2021
E&O G.S.M. 16.04.2024
National anti-corruption strategy
2020
Presentation of the quarterly report – Q1 – 2024
Antibiotice Iasi invests in digitalization for the transition to a sustainable business
G.S.M. 29.02.2024
Catalin LUNGU
The Antibiotice Iași business growth by 24% in 2023 strengthens the company’s development
On April 17, 2024 Antibiotice SA (symbol ATB) submitted to the Bucharest Stock Exchange the admi...
1955
1955-1959 In December 1955 the Chemical Plant no. 2 was established in Iaşi, being Romania’s an...
Antibiotice Iasi invests in digitalization for the transition to a sustainable business
Commissioning of the 2.5 MW Photovoltaic Power Plant
Catalin Codrut POPESCU
2019
Pharmacovigilance – medicines for human use
Meeting with investors and analysts – presentation of 1st quarter 2024
2020
2019
E.G.S.M. 30.10.2023
The Antibiotice Iași business growth by 24% in 2023
Aurelia TALPOS
Paracetamol 500 mg, tablets
2018
The Antibiotice Iași business growth by 24% in 2023 strengthens the company’s development
Pharmacovigilance – medicines for veterinary use
Presentation of half-yearly report 2024
1960
1960-1977 New technological flows are developed that manufacture various active ingredients (er...
Lisinopril Atb® 10 mg, tablets
Resignation of an administrator/Appointment of an Interim Administrator
2018
O&E G.S.M. 14.09.2023
2017
Reference documents
1977
1977-1989 In the 80’s Antibiotice already exported 50% of its output. The active ingredients ma...
Ethionamide Atb® 250 mg, film-coated tablets
Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, financed by the RRRP, which will provide over 25% of the electricity requirements
the 2.5 MW ground photovoltaic plant will provide 26.4% of the company's electricity needs ...
Antibiotice Iasi lanseaza o noua gama de produse veterinare
Presentation of the quarterly report – Q3 – 2024
Ethambutol Atb® 250 mg, film-coated tablets
Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, financed by the RRRP, which will provide over 25% of the electricity requirements
Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant
Viorela ZAHARIA
2017
2016
Eng. Cornelia MORARU
Meeting (teleconference) with investors and analysts – Presentation of the quarterly report – Q3 – 2024
1990
1993-1997 Over this time interval we have made major investments amounting to over eight millio...
Betahistina Atb® 24 mg, tablets
O.G.S.M. 27/28.04.2023
2015
O.G.S.M. 02/16/2023
Levofloxacin Atb® 250 mg, film-coated tablets
1997
1997 Antibiotice shares (ATB shares) have been listed on the first category of the Bucharest St...
2016
Ec. Ovidiu BATAGA
Levofloxacin Atb® 250 mg, film-coated tablets
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
O&E G.S.M. 16.09.2022
2015
2014
2000
2000-2004 Constant investments in research, in staff training, in quality and in revamping th...
Antibiotice Iasi maintained the growth trend of turnover and profitability in the first 9 months of 2023
Antibiotice SA (ATB symbol) submitted to the Bucharest Stock Exchange, on Wednesday, November 15...
2013
Ec. Paula-Luminita COMAN
Sinerdol® 150 mg, hard capsules
O&E G.M.S. 04/27/2022
Information Regarding GSM materials 16.02.2023
Liviu VATAVU
2005
2005: a breakthrough year Antibiotice reported an important boost of both profit and turnover -...
Physiological serum 9 mg/ml
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2013
Antibiotice Iasi maintains the growth trend of turnover and profitability in the first 9 months of 2023
2012
O.G.S.M. 28.02.2022
First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines
Tigeciclina Atb® 50 mg
First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines
EIB loan is expected to enhance local production of medicines Financing agreement promote...
2007
2007: the year we gained several pluses In 2007, Antibiotice gains recognition for the implemen...
Vancomicina Atb® 500 mg, powder for concentrate for solution for infusion
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
Ec. Darius Giorgiani AGAFITEI
2012
2009
2009 – Antibiotice's oriented towards international growth Antibiotice continued to reach highe...
Vancomicina Atb® 1000 mg, powder for concentrate for solution for infusion
O&E.G.S.M. 26/27.08.2021
2011
2011
First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines
Pharmacist Daniela PASCARIU
Cefazolina Atb® 1 g
We build the future together with our partners!
Notice of availability 2023 Q3 Report
2010
O.G.S.M. 20/21.04.2021
2010
2010 - 2011: Following the crisis, Antibiotice will reemerge stronger and ready to meet the chal...
Ertapenem Atb® 1 g
Psychologist Mihaela MURARIU
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2010
Antibiotice announces the selection of the European Investment Bank to finance investment projects worth EUR 25 million
A working team for carrying out the procedures and activities necessary for the procurem...
Signing of the Financing Contract with the European Investment Bank
G.M.S. 11/02/2020
Antibiotice takes an important step towards sustainable development and becomes a member of the Sustainable Romania Coalition
Whistleblowers in the Public Interest
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2009
2012
2012 - 2013: Antibiotice defines strategic directions for the coming years Antibiotice continue...
Ec. Stefania ALEXANDRU
Multiplying the export of Antibiotice Iasi 9 times in the last twenty years. We create the future together with our partners!
These days, Antibiotice Iasi is present for the 20th consecutive year at the most important exhi...
Governance documents
2008
2014
2013 – 2014 Antibiotice becomes the world’s leading manufacturer of Nystatin In line with th...
GMS 09/16/2020
2008
Independent Auditor’s Report on the compliance of the XHTML Electronic Format with the requirements
2022 Dividend payment
GMS O&E 05/20/2020
2007
2015
2015 - Antibiotice gets the USFDA reaproval for the sterile injectable finished products and Nys...
Eng. Gianina Gabriela MACOVEI
Multiplying the export of Antibiotice Iași nine times in the last 20 years. We build the future together with our partners!
These days, Antibiotice Iași is present for the 20th consecutive year, at the most important exh...
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
A new GLP certification obtained by the Clinical Studies Center (CSC) @ Antibiotice Iași
GMSO&E 09/10.04.2020
2005
2006
Availability for the H1 Report 2023
National anti-corruption strategy
Antibiotice takes an important step towards sustainable development and becomes a member of the Sustainable Romania Coalition
Antibiotice, the most important pharmaceutical producer with Romanian capital, became a member...
2017
Antibiotice imposes worlwide the quality standard for Nystatin by obtaining the title of intern...
G.M.S.O. 05/06.03.2020
A new auction won by Antibiotice in the UK
2016
2016 Record delivery of injectable products for the USA (Nafcilina of 1g and 2 g and Amp...
2005
Information Regarding GSM materials 28.02.2022
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2004
Tender United Kingdom
G.M.S.O.&E. 10.09.2019
2004
Antibiotice attracts funds from PNRR for green energy production
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2018
2018 Antibiotice won the third place at the "Romanian CSR Awards 2018", in the Intersectoral...
Candesartan ATB® 16 mg, tablets
G.S.M.O & E. 18.04.2019
2003
A new GLP certification obtained by the Clinical Studies Center (CSC) @ Antibiotice Iași
Our company's Clinical Research Center (CSC) has received the approval that allows it to continu...
Current report Manager’s transactions art. 19 Reg. (UE) 596/2014
2019
2019 Antibiotice begins the serialization of its pharmaceutocal products; The firs...
Financing for a new investment in production and research capacity
News archive
Notice of availability 2023 Q1 Report
GSM 25.09.2018
Candesartan ATB® 8 mg, tablets
Antibiotice 65
Availability for the Annual Report 2022
A new auction won by Antibiotice in the UK
Our company has won a new auction worth 5 million euros for the distribution of injectable drugs...
Current report – Threshold more than 25% notification
GMS 04/26/2018
The economic and financial results recorded in 2022
Advisory service agreement ATB-BEI
Sinerdol® 300 mg, hard capsules
Antibiotice attracts funds from PNRR for green energy production
The Antibiotice Company announces today the obtaining of a new non-refundable financing, after t...
GMS 05.03.2018
Perasin® 4 g/0.5 g
SIF Oltenia transaction notification
Availability for the Annual Report 2022 – PRELIMINARY RESULTS
Perasin® 2 g/0.25 g
BIOCIDES
BIOCIDES In the context of the health crisis caused by the Covid pandemic19 and as a resu...
Financing for a new investment in production and research capacity
On May 17, 2023, Antibiotice SA, the most important Romanian manufacturer of generic drugs obtai...
The European Investment Bank and Antibiotice signed an advisory service agreement for the strategic development of the industrial site of the company
OGMS 09/20/2017
Notice of availability Raport Q3 2022
Appointment of the Chairman of the Board
2021 Dividend payment
Financing for a new investment in production and research capacity
On May 17, 2023, Antibiotice SA, the most important Romanian manufacturer of generic drugs obtai...
Lejer Anti-Gas
Current Report 27.05.2021
OGMS 06/28/ 2017
Ampiplus® 2000 mg/1000 mg
Cessation of dividend payment 2018
Events
2024 Romania Investor Days Wood & Company in partnership with the Bucharest Stock E...
O&EGMS 04/06/2017
Faguria® oral spray
GMS 08.11.2016
Notice of availability 2022 H1 Report
Analist coverage
BRK Financial Group - Ioana MAIER IFB FINWEST - Broker - Florin TURCAS
Faguria® Lozenges
Market Maker Services Contract
GMS 04/19/2016
Notice of availability – 2020 Annual Report
The European Investment Bank and Antibiotice signed an advisory service agreement for the strategic development of the industrial site of the company
Yesterday, April 19, in Luxemburg, high-level officials of the European Investment Bank (EIB) an...
Notice of availability for the Report on 31 March 2022
Non-financial reports
The Integrated Annual Report of the Antibioticecompany for the year 2023 can be accessed...
Availability for the Annual Report 2021
GMOS 04/30/2015
Current report – Threshold more than 20% notification
Antibiotice Iași inaugurates the most modern topical medicine factory in Europe
Nutriensa
Antibiotice has entered the US and UK markets with new medicines for Covid-19
Availability for the Annual Report 2021 – Preliminary results
GMS 08/13/2015
Dividend payment 2018
AGA 14.08.2014
Cessation of dividend payment 2015
Tender result in the United Kindom of Great Britain
Equilibra® Plus
GMS 26.06.2014
Cessation of dividend finanical year 2015
GMS 04/25/2014
Processing personal data
GENERAL INFORMATION NOTE ON PROCESSING PERSONAL DATA I. WHO ARE WE? ANTIBIOTICE SA (hereinafte...
Notice of availability 2021 Q3 Report
Dividend payment 2020
Current report – Threshold more than 15% notification 23.11.2018
Aceclofen®
Dividend payment 2020
Cessation of dividend payment 2014
GMS 03.20.2017
Cessation of dividend payment – financial year 2017
Cookie Policy
Cookie Policy About Cookies The website www.antibiotice.ro utilizes cookies. The informat...
Terms and conditions of use
Terms and conditions of use Site-ul www.antibiotice.ro is the property of S.C. ANTIBIOTICE S.A....
GMP certificate granted by ANMDM for the new factory of Topic products
Today, December 9, was a day that will remain a landmark in our 67-year evolution, and which tou...
Notice of availability for the Report on 30 June 2021
Current report – Dividends cut 2013
Alprazolam Atb® 1 mg
Presentations
- 2024 - Presentation-for-investors-H1 - 2023 - Presentation-for-investors - 2022 - ...
Antibiotice Iași inaugurates the most modern topical medicine factory in Europe
On the occasion of the anniversary of 67 years of activity, Antibiotice Iași inaugurates today, ...
Notice of availability Report TRIM. I 2021
European Projects
Intelligent Energy Monitoring System of Antibiotice SA Antibiotice SA, the leading producer of ...
Amoxicillin Atb® 250 mg, hard capsules
Antibiotice Iași – first place in the ranking of the most competitive companies in Romania
The notable performances and results recorded by Antibiotice Iași in 2022 were awarded on Novemb...
AGAO 25.04.2013
Current report
Notice of availability – 2020 Annual Report
Amoxicillin Atb® 500 mg, hard capsules
Amoxiplus® 1000 mg/200 mg, powder for solution for injection/infusion
BVC 2016
Antibiotice Iasi, the best company in communication with Investors, in 2022
With a presence of over 25 years on the capital market, the company Antibiotice Iași won first p...
Investitori formular
Notice of availability 2020, Q3 Report
Current Report on OUG 29/2017
Amoxiplus® 875 mg/125 mg, film-coated tablets
Dividend payment 2019
World Antimicrobial Awareness Week
The "George Emil Palade" classroom of UMF Iași was, on Wednesday, November 16, filled with over ...
Ampicilina Atb® 1000 mg
Contact for Investor Relations
Cerasela-Simona VASILIU Investors Relation Officer Tel: 0372065 583 Email: relati...
Cessation of dividend payment – financial year 2016
European Project
Participation in CPhI Worldwide – the engine for multiplying the export of Antibiotice
Multiplying more than 7 times the export Market shares of over 30-40% in the US, UK and Vietnam...
Ampicilina Atb® 250 mg
Notice of availability 2020 H1 Report
Contract manufacturing
Contract manufacturing We have certified manufacturing capabilities, our staff is skilled and t...
Ampicilina Atb® 500 mg
Investors
Ampicillin Atb® 250 mg, hard capsules
European Mobility Week at Antibiotice
The Antibiotice Company joined the European Mobility Week (September 16-22) through actions to p...
Statement on accession to the National Anticorruption Strategy 2016 – 2020
Notice of availability 2020, Q1 Report
Ampicillin Atb® 500 mg, hard capsules
Antibiotice – a Made in Romania company, awarded by BVB
The Antibiotice Company was awarded today, by the Bucharest Stock Exchange, during the Made in R...
Ampiplus® 1000 mg/500 mg
Notice of availability 2019 Annual Report
CEO’s Message
Message of the CEO, Ioan Nani Following its destiny, our company turned over the last 68 years ...
World Patient Safety Day 2022
World Patient Safety Day is marked annually on September 17. The World Health Organization (WHO)...
Notice of availability of preliminary report 2019
Involvement in training the health care professionals
The Hippocratic spirit that guides medical practice in general, guides our business activity and...
Water for injections
Perform a+
Perform a+ program is part of the continuous education and communication platform that Antibioti...
Notice of availability 2019 Q3 Report
Dividend payment 2018
Q1 / 2022
The results obtained by Antibiotice show sustainable growth determined by the consistent applica...
Betahistina Atb® 8 mg, tablets
Information for shareholders
Antibiotice on the securities market Traded under the ATB symbol, our company's shares are issu...
Bisotens® 10 mg, film-coated tablets
Notice of availability for the Report on 31 March 2019
Medical devices
Doors Open Days at Antibiotice Iasi
The company Antibiotice under the motto "A friendly and responsible brand" opened its doors to v...
Bisotens® 5 mg, film-coated tablets
Availability for the Annual Report 2018
Pharmacovigilance form
Notice of availability for the Annual Report 2018 – PRELIMINARY RESULTS
Bromhexin Atb® 8 mg, tablets
Cefalexin Atb® 500 mg, hard capsules
Notice of availability for the Report on 30 September 2018 2018-11-14
Quality Policy
The policy on quality, environment, occupational health and safety We want to improve peoples’ ...
Cefalexin Atb® 250 mg, hard capsules
High-level visit of 28 ambassadors
New opportunities for consolidating the Iași Antibiotics business on the international market ...
Staff training
Knowledge and continuous improvement Knowledge and continuous improvement are essential for o...
Notice of availability -2018-H1-Report
Dividend payment 2017
Antibiotice celebrates 25 years of history at the Bucharest Stock Exchange
On Friday, April 15, BVB opened the trading session together with the Antibiotice Iasi team to c...
Careers
Antibiotice Careers We mutually acknowledge our purpose and value and that brings us closer t...
Ceforan® 500 mg, capsules
Availability for the Annual Report 2017
Centre for Drug Evaluation
The Centre for Drug Evaluation (CDE) is a research unit authorized by the Romanian Ministry of H...
Cefort® 1 g
Accelerated sales revenue and profit growth in Q1 / 2022
Today, May 13, 2022, Antibiotice SA (symbol ATB) submitted to the Bucharest Stock Exchange, the ...
Cefort® 2 g
Notice of availability for the Report on 31 March 2018
Comunicat disponibilitate Raport anual 2017
Zifex® Complex
Ethics practices reporting
Procedures of the General Meeting of Shareholders
Earth Hour taking place at Antibiotice Headquarters
Today, March 26, 2022, between 20:30 and 21:30, the company Antibiotice will symbolically turn o...
Cefort® 250 mg
Public Interest Announcements
Sorry, this entry is only available in Romanian. For the sake of viewer convenience, the conte...
Availability for the Annual Report 2017 – PRELIMINARY RESULTS
Cefotaxima Atb® 1 g
Biotechnologies
Opportunities for collaboration in biotechnology research Throughout more than 60 years of indu...
Romanians will have potassium iodide
Antibiotice Iași has started the distribution of this product to the Public Health Directorates ...
Ceftamil® 1 g
Cefuroxima Atb® 1.5 g
Notice of availability Annual Report 2016
Events Calendar
In accordance with the Chapter VI, Section 2, Art. 92 of the Bucharest Stock Exchange Code, we a...
Cefuroxima Atb® 750 mg
Regulatory Affairs
Expertise in Regulatory Affairs Regulatory Affairs is the interface between pharmaceutical ...
Dividend payment in 2016
Antibiotice company ranks high in evaluating sustainability performance
The company Antibiotice Iași is in the top 5% in the pharmaceutical sub-industry out of a total ...
Antibiotice Iași obtained a grade of 10 in the VEKTOR evaluation for excellent communication with investors
For the third consecutive year, Antibiotice Iași obtains the highest grade in the VEKTOR ranking...
Availability Preliminary Results 2016
Quality
Internationally certified quality Quality assurance, efficiency and safety of our products, a...
Antibiotice obtained maximum grade in the VEKTOR evaluation for excellent communication with investors
For the third consecutive year, Antibiotice Iași obtains the highest grade 10 in the VEKTOR rank...
Clinical trials
Clinical Trials The clinical trials conducted within the Center for Drug Evaluation are previou...
Leprechauns from Antibiotice have brought the joy of Christmas to 80 needy children
The joy of a Christmas with fulfilled wishes was lived by 80 children from needy families, from ...
Cycloserine Atb® 250 mg, capsules
Availability Report Q2
Research
Research, a constant preoccupation All development processes of generic drugs are condu...
Cessation of dividend payment – financial Year 2012
Company
Science and soul, in the best interest of patients With both science and soul, Antibiotice ma...
Dividends payment
Cipro Quin® 500 mg, film-coated tablets
Zifex Duo® 500 mg/200 mg
Antibiotice company classified in the GOLD category in the Romania Corporate Sustainability & Transparency Index 2021 ranking
Romania CST Index Today, December 9, 2021, during the Best Practices in Corporate Sustainabil...
News release and current reports
Up-to-date information for investors and shareholders can be found within the news release secti...
Clafen® 10 mg/g
BVC 2016
Press releases
2024 Press release financial results of the first semester of 2024 Antibiotice Iasi invests ...
Clafen 10mg/g
11 million euro bid won by Antibiotice in the United Kingdom
The company Antibiotice Iași won the tender organized by the Ministry of Health from the United ...
Report of compliance with the BSE Corporate Governance Code
Contact
Clafen® 50 mg/g
Antibiotice for over 20 years in the NATIONAL TOP of COMPANIES
The performances of the Antibiotice company were appreciated by the Romanian Chamber of Commerce...
Media Relation Contact
Media Relation Contact For all media related enquiries, please contact: Mihaela Melinte Com...
Paymont of dividends 2014
European Antibiotics Information Day – 18 November
On the occasion of the European Antibiotic's Information Day (November 18), Antibiotice company ...
18 years of participation in Antibiotice at CPhI Worldwide
We build the future together with our partners. On November 9- 2021, a delegation from Antibi...
Corporate Governance
Corporate Governance The principles and recommendations of the Corporate Governance Code of t...
News release 03.10.2014
Clo-Ekarzin 0,50mg/10mg/g
Clobetazol Atb® 0,5 mg/g
Company Info
Antibiotice’s financial results in the first 9 months, 2021 – part of the Strategic Organization and Development Plan
Antibiotice has adapted its business strategy to the new market conditions, the development desi...
Development
We develop generics with proven therapeutic efficacy and safety of administration Anal...
Suspending payment of dividends in 2011
Zulin® 30 mg
News release 21.02.2013
ARIR PERFORMANCE AWARDS for companies listed on the Bucharest Stock Exchange
ARIR PERFORMANCE AWARDS for companies listed on the Bucharest Stock Exchange. The Association f...
Reports
Curent Report 20.02.2013
Cutaden®
Online dividend request form
Integrated promotion of food supplements from the Nutriensa® range
Antibiotice, together with Dr. Max pharmacies, is running an integrated campaign to pr...
Cutaden® bebe
The first 5 graduates of “Perform a +” this year joined the company team
The graduates of the “Perform a +” edition of 2021 received their graduation diplomas on Novembe...
Reference documents
Escitalopram Atb® 10 mg
100 Most Admired CEOs in Romania
"100 Most Admired CEOs in Romania", the only yearbook of Business MAGAZINE organized in the form...
How to contact us
Doxycycline Atb® 100 mg, hard capsules
Science and Soul Foundation
Science and soul brings us closer to our community Thanks to our foundation "Antibiotice - Sc...
Antibiotice’s Volunteers donate blood to the 20th donation action organized by the company
Solidarity with people! Solidarity with life! Over 70 Antibiotice employees donated blood dur...
Eficef® 100 mg, hard capsules
Ioan Nani, CEO Antibiotice, invited to the Conference “Health and PHARMA – The health system, under the fourth wave”
"This crisis creates the opportunity to better organize ourselves as a country" Invited to th...
Home
Antibiotice, a profitable company The investments in research, quality, as well as in the moder...
Eficef® 200 mg, hard capsules
Antibiotice supports World Patient Safety Day. Commitment to patient safety
The Antibiotice Company carried out today, on World Patient Safety Day, a series of actions to i...
Antibiotice in the world
Antibiotice on foreign markets Exports to over 70 countries worldwide More than 120 busines...
Equilibra®
Clafen® 100 mg
Antibiotice – a brand of the employer of the future!
Antibiotice hosted 50 students from disadvantaged backgrounds, included in the "Choose to be a p...
Antibiotice ends the first half of 2021 with a net profit of 19.3 million lei
In the first half of the year, Antibiotice Iaşi reached a turnover of 163.4 million lei, 11% hig...
Governance structure
Financial information
Financial balance and yields increase Antibiotice operates in the spirit of achieving the objec...
World Blood Donor Day @Antibiotice
On World Blood Donor Day, 11 employees of our company donated blood to the Regional Blood Transf...
Ethambutol Atb® 400 mg, film-coated tablets
Advisory Committees
Indometacin 50 mg
New investors
Antibiotice, a company worth investing in The investments in research, quality as well as in th...
Fezivit C®
History
History Here at Antibiotice we are committed to human health care, providing high-quality gener...
Open Positions
Open Positions Join the Antibiotice team for more and for better for people’s health! For 68 y...
Fluocinolone N Atb® 0,25 mg/5mg/g
Fluxiv®
Certifications
Certifications 2022 Due to the restrictions caused by COVID-19, the period of validity o...
Fluxiv® tonic cream
Through the “Power of Deed” the “Antibiotice – Science and Soul” Foundation offered joy to 187 children
Through the "Power of Deed" the "Antibiotics - Science and Soul" Foundation offered joy to 187 c...
Pyrazinamide Atb® 500 mg
Media
We are a transparent company and believe that delivering accurate and timely informati...
Isoniazid Atb® 300 mg
Medicines with prescription
Antibiotice’s volunteers celebrated “Earth Day” by planting oxygen in the community
Today, on the occasion of the International Earth Day, 50 Antibiotic employees voluntarily parti...
Isoniazid Atb® 100 mg
Over the counter drugs
Responsibility towards the community and employees awarded at the Romanian CSR Awards 2021 Gala
Our company obtained today, April 8, 2021, at the Romanian CSR Awards Gala 2021, the 1st place i...
Medicines for human use
In the midst of the pandemic, Antibiotice doubled their investments
In 2020, a year affected by the pandemic with the SARS COV-2 virus, the Antibiotice company doub...
Roclarin® 500 mg
Medicines for veterinary use
Antibiotice manufactures powders for injectable suspensions and ointments for veterinary use Ou...
No side effects! No missed dose of vaccine!
Less than two weeks after the establishment of the Covid 19 Vaccination Center, within its own C...
Mission and values
The mission, vision and values of our company Company mission We make our valuable medicines m...
Imipenem/Cilastatin Atb® 500 mg/ 500 mg
Multimedia
Antibiotice company obtained the maximum points for communication with investors
For the second consecutive year, Antibiotice obtained a grade of 10 in the ranking of the ...
Nystatin
World-leading manufacturer of Nystatin Antibiotice is renowned for being a worldwide to...
Antibiotice involved in the anti-COVID19 vaccination campaign
Hundreds of Iași residents and Antibiotice Iași employees will be vaccinated every day at the Va...
Potassium iodide Atb® 65 mg, tablets
News
Partners
We have a healthy and sustenable growth along with our partners Our development, in a global wo...
Foreign partners
Developing exports, a strategic priority With experience in the export business for over 40...
Kanamicina sulfat 1%
Local Partners
Continuous and active presence on the market To medical professionals worldwide we offer a po...
Nofloxacina Atb® 400 mg
Academic Partnerships
Partnerships with academic institutions It was not coincidentally that Antibiotice, the facto...
Kanamicina sulfat H
Antibiotice Iași: One of the most used antibiotics in pandemic won the auction organized by the European Commission
The fight against the SARS-CoV-2 virus has led Europe to take safety measures against ...
Meropenem Atb® 1000 mg
The policy on quality, environment, occupational health and safety
The policy on quality, environment, occupational health and safety We want to improve peoples' ...
Meropenem Atb® 500 mg
Exports in the first six months supported the company business in the midst of the pandemic with COVID-19
With the onset of the SARS-CoV-2 virus pandemic at the end of the first quarter of 2020, the org...
Sport partnerships
Antibiotice has supported Iasi volleyball for more than fifty years Penicillin Iasi volleybal...
Erytromycine Atb® 200 mg
Antibiotice company have entered the US and UK markets with new drugs associated with Covid-19
Against the background of the pandemic with the SARS-CoV-2 virus, while the Romanian hospital an...
Recognition and awards
Recognition and awards The results of our company have been recognized over the years by major ...
Presentation
Antibiotice, romanian continuity and performance Starting with penicillin, our first product ...
Antibiotice company at Pharma video-conferences
The role of the Romanian medicine industry in public health administration during this period. ...
Lisinopril Atb® 20 mg, tablets
Products
Our products We manufacture high-quality generic medicines that enable us to expand the access ...
Lisinopril Atb® 40 mg, tablets
Finished products
Export products We have an extensive portfolio of generic drugs with documentation in CTD forma...
Colistin Atb® 1.000.000 UI
Enviromental Protection
Environmental protection Since December 2010, Antibiotice owns the Integrated Environmental Aut...
Memantine Atb® 10 mg, film-coated tablets
Annual reports
“Antibiotice Science and Soul” Foundation takes care of 25 former employees of Antibiotice
As of April 2, 25 seniors, former employees of the Antibiotic company, benefit from food assista...
Memantine Atb® 20 mg, film-coated tablets
Financial reporting
Antibiotice Iași implements all possible measures for the safety of employees and the continuity of drug deliveries
In the context of the extension of the coronavirus pandemic (COVID19) since mid-February, the ma...
Complains
[contact-form-7 id="10680" title="Formular reclamatii Engleza"]
Responsibility
Responsibility As a pharmaceutical manufacturer, Antibiotice manufactures medicines on scient...
Moldamin® 1.200.000 UI
Support the projects carried out by the Science and Soul Antibiotic Foundation ”and in 2020.
The 230 forms collection campaign for the redirection of the income tax has started! By redir...
Corporate Governance Regulation
Corporate Governance Regulation (...in working progress)
Naftifine Atb® 10mg/g
Archive of The General Meeting of Shareholders
The General Meeting of Shareholders The General Meeting of Shareholders (GMS) is the highest de...
Antibiotice awarded for excellent communication with investors
Antibiotice company obtained 10 mark - Excellent communication in Investor Relations - in a ran...
Dividends handout
Dividends In accordance with the provisions of the capital market legislation, the payment of d...
Antibiotice Co resumed production of Moldamin
Antibiotice relaunches the production of Moldamin® 1200000 IU powder for suspension for injectio...
Stock Quotes
The nominal value of a share ATB = 0.10 lei / share. Antibiotice Iasi is listed in Cate...
Nystatin 500.000 U.I.
Social responsability
Responsibility As a pharmaceutical manufacturer, Antibiotice manufactures drugs on scientific b...
Summer School a+
Summer School In the fields of research, development and pharmaceutical formulation, quality as...
Nistatina Atb® 100000 UI
Nobixal® 12.5 mg, film-coated tablets
Selecting volunteers
Selecting volunteers For conducting the bioequivalance studies we collaborate with over 1.000 h...
Serbian Health professionals visiting Antibiotice Iasi
At the invitation of the Antibiotic company, on Friday, November 29, 2019, a delegation from Ser...
Services
Complete studies at international standards Our 10-year experience allows us to approach va...
Nolet® 5 mg, tablets
Antibiotice company awarded by ANEIR for Nistatin product
For the performance achieved of being for more than 5 years the world leader for Nistatin produc...
10 % increase in the gross profit in the first 9 months of 2019
The financial results of Antibiotice Iași in the first 9 months of 2019 indicate a 10% increase...
Pharmacovigilance
Safe, effective and high-quality medicines Antibiotice medicines safety is monitored by the...
Novocalmin® 300 mg, suppositories
We planted O2 in our community
Social responsibility action of Antibotice company. Today, November 6, 60 employees of Antibi...
Novocalmin® 500 mg, tablets
Meeting with investors
- 2022 - Q3 2022 Teleconference ANTIBIOTICE S.A. Iasi informs its investors that, on No...
CPHI Worldwide 2019 – New business opportunities for Antibiotice
Between November 5 and 7, in Frankfurt, Antibiotice is present at the CPhI Worldwide 2019 (Conve...
Omeprazol Antibiotice® 20 mg, gastro-resistant hard capsules
Integrated Management System
Integrated Management System We believe in creating a culture of quality, responsibility toward...
Oxacillin Atb® 250 mg, hard capsules
Antibiotice SA publishes the second non-financial report “Responsible for a better life”
"Responsible for a better life" is the concept by which Antibiotice SA launches the second non-f...
Studies
Validated studies and bioanalytical methods Fully respecting the GLP principles, the GLP auth...
Oxacillin Atb® 500 mg, hard capsules
Active pharmaceutical ingredients
Antibiotice is the leading worldwide manufacturer of industrial-scale production of Nystatin ...
Oxacillin Atb® 1000 mg
Cosmetic products
Oxacillin Atb® 500 mg
Vietnam’s ambassador, visiting the company that provides a quarter of the exports to this country
On the occasion of his visit to Iasi County, His Excellency Dang Tran Phong, the ambassador of t...
Transactions for the initiated persons
Sales revenue and profit earned by Antibiotice in the first semester of 2019 recorded higher values compared to those in the same period of 2018
Sales revenue and profit earned by Antibiotice (BVB: ATB index) in the first semester of 2019 re...
Mastoprofen® 10 mg/g
Antibiotice associates with ARIR
The Romanian Investor Relations Association (ARIR) is delighted to associate with Antibiotice (B...
Triamcinolone S
Sal-Ekarzin® 0,50 mg/30 mg/g
“Summer School a+”, an incubator for the Antibiotice future specialists
The tenth edition of Summer School a+ organized by Antibiotice under the slogan This summer, sci...
Paracetamol Atb® 125 mg, suppositories
Our current pharmacists face to face with the aspiring pharmacists!
"Antibiotice is the company where your passion turns into your profession". This is how two of o...
Paracetamol Atb® 250 mg, suppositories
Nidoflor®
Paroxetina Atb® 20 mg
Visit of an Israel delegation to Antibiotice
Antibiotice was yesterday host of a delegation from Ashdod (Israel), led by Mayor Yechiel Lasry....
Mometasone Atb® 1 mg/g
Penicillin G potassium Atb® 1.000.000 U.I.
2019 Stock Exchange Inauguration Gala
On February 19, 2019, Antibiotice participated as a Silver Partner at the sixth edition of the I...
Mometasone Atb® 1 mg/g
Penicillin G sodium Atb® 1.000.000 U.I.
Employee children, celebrated with colorful balloons and invitation to … childhood!
It has already become a tradition for Antibiotics to offer a gift to the children of their emplo...
Hydrocortisone 1%
Bucharest Stock Exchange in visit to Antibiotice
Antibiotice received yesterday the visit of a delegation from the Bucharest Stock Exchange, repr...
Penicillin G sodium Atb® 400.000 U.I.
Ekarzin® 0.5 mg/g
“Antibiotice Science and Soul” Foundation brought light to 23 needy families
On the occasion of the Easter holidays, the Antibiotice Science and Soul Foundation came to the ...
Ramipril® 10 mg, tablets
Audited economic and financial results of 2018 – 8% increase in sales revenue and 2% profit after tax
The General Shareholders' Meeting, held on Thursday, April 18, 2019, approved the audited financ...
Ramipril® 2.5 mg, tablets
Antibiotice at the Romanian-Vietnam Business Forum
Antibiotice Company participated on Monday, April 15, at the Romanian-Vietnam Business Forum org...
Ramipril® 5 mg, tablets
Antibiotice received two awards at the Romanian CSR Awards Gala
Antibiotice Company has won two awards at the Romanian CSR Awards 2019: the first place and the ...
Rompirin® E 100 mg, gastro-resistant tablets
Rosuvastatin Atb® 5 mg, film-coated tablets
Almacor® 10 mg
Delegation of the French Chamber of Commerce visiting Antibiotice
On Wednesday, March 6, 2019, Antibiotice received the visit of a delegation from the French Cham...
Rosuvastatin Atb® 10 mg, film-coated tablets
Revenue from sales up 8% and net profit up 2%
Weighing strategic objectives with an emphasis on business internationalization, in 2018 Antibio...
Almacor® 5 mg
Antibiotice Company awarded at ANEIR Gala
Antibiotice Pharmaceutical Company was awarded by the National Association of Exporters and ...
Rosuvastatin Atb® 20 mg, film-coated tablets
Rosuvastatin Atb® 40 mg, film-coated tablets
Antibiotice – 63 years of continuity and Romanian performance
Just a few days after the anniversary of the Romanian centenary, Antibiotice Company marked the ...
Gladycor® 25 mg
Gladycor® 12.5 mg
Antibiotics of the 3rd Millennium
Antibiotice SA launched the Antibioticele Millennium III social responsibility program by bringi...
Gladycor® 6.25 mg
Antibiotice, 1st prize in National Firm Industry
Antibiotic performance in the past year has been rewarded with the First Place Prize in the Farm...
Silithor®
Antibiotice launches first non-financial report 2017
"Together for a Better Life" is the concept by which Antibiotice SA launches its first non-finan...
Hemorzon®
Hemorzon®
Each of us can save a life!
100 Antibiotice employees were trained to provide first aid 100 employees of Antibiotice partic...
Antibiotice’s employers donated blood
50 donors, 25 liter donated blood, more than 130 saved lives! These are the figures of the fift...
Sinerdol® Iso 300 mg/150 mg, hard capsules
Antibiotice participates in CPhI Worldwide 2018
For the 16th consecutive year, Antibiotice participates in CPhI Worldwide 2018 (Chemical and Pha...
Open Door Day dedicated to ATB’s Shareholders, Investors and Analysts
Antibiotice Iasi (ATB) invites you to Open Door Day dedicated to ATB's Shareholders, Investors a...
TOP Positions for Antibiotics in Iasi
Following the analyzes made by the Chamber of Commerce Iasi on the economic performances of the ...
Sales income higher by 7% and net profit up by 5% during the first half of 2018 compared to the first semester of 2017
The profit and sales revenue obtained by Antibiotice (BSE index: ATB) during the first half of 2...
A new edition of the Summer School a+ Antibiotice is training its future specialists
The latest edition of the Summer School a+ organized by Antibiotice has been a notable success. ...
Antibiotice Open Day on Enviromment
Antibiotics use responsible resources, meet the highest quality standards for the manufacture of...
Soriso®
Spaverin® 40 mg, capsules
Antibiotice prepares future researchers
For the third consecutive year, the Perform a+ program organized by Antibiotice, attracts the at...
Spaverin® 80 mg, capsules
Saliform® Forte
Children’s 3D Day at Antibiotice
Children's 3D Day at Antibiotice It has become a tradition for Antibiotice to offer a gift to...
Sprinten®
New business opportunities for Antibiotice
High-level visit of 22 ambassadors Representatives of 14 embassies in Romania visit during th...
Phenylbutazone 4%
An increase by 10% of the net profit
The main decisions of the Ordinary and Extraordinary General Meeting of Shareholders of Antibiot...
Glycerol suppositories for adults
We support community education and prepare for the future
Antibiotice’s employees support 70 students at risk of dropping out of school For the sec...
Glycerol Suppositories for children
“School Orchard” gets roots in two schools in Leţcani
On Saturday, April 21, 2018, over 70 Antibiotice volunteers were involved in the "School Orchard...
Tetracycline Atb® 250 mg, capsules
The Antibiotice company employees have donated blood!
60 donors, 30 liter donated blood, more than 150 saved lives! These are the figures of the ...
Antibiotice Science and Soul” Foundation brought light to 26 needy families
On Easter holidays, the Antibiotice Science and Soul Foundation helped 26 families with 124 chil...
Neopreol® 2.5 mg/5 mg/g
Tetracycline Atb® 30 mg/g
Antibiotice rewarded at the Romanian CSR Awards 2018
Antibiotice Company won 3rd place at the "Romanian CSR Awards 2018", within the Intersectoral Pa...
Cicatrol® 10 mg/g
World Day Against Tuberculosis – March 24, 2018
What do you know about tuberculosis? Tuberculosis is the infectious disease produced by Mycob...
Tinero®
Taficen® 10 mg/g
Antibiotice supports Earth Hour
Saturday, March 24, 2018, Earth Hour, between 20:30 and 21:30, and Antibiotice will symbolically...
Antibiotice’s employees were Santa’s elves for 80 children in need
For the fifth consecutive year, the „Antibiotice - Science and Soul” Foundation in cooperation ...
Tuadin® 10 mg, film-coated tablets
Compania Antibiotice premiată la Gala ANEIR
On Tuesday, December 12, 2017, Antibiotice was awarded the ANEIR Trophy of Excellence for its p...
Clotrimazole Atb® 10 mg/g
Zatinex® 30 mg, gastro-resistant capsules
Zatinex® 60 mg, gastro-resistant capsules
Antibiotics save lives! Use them responsibly!” Caravan reaches three towns from the Iasi County
Between November 18 and 25, 2017, to mark the European Antibiotic Awareness Day, Antibiotice off...
Antibiotice Iasi – 2017 Q3 financial results: sales revenues up by 4% and net profit up by 37%
The results of Antibiotice in the first 9 monhs of 2017 show that the sales revenues amounted to...
Zolpidem Atb® 10 mg, film-coated tablets
Antibiotice Iasi, among top Romanian business entities
The Chamber of Commerce and Industry of Romania, the most important institution speaking on beha...
CphI:15 years of participation to the world’s leading pharmaceutical event
Between 24-26 October 2017, Antibiotice participated for the fifteenth consecutive year as an ex...
Antibiotice attends the most important conference on phytotherapy in Romania
Between October 20th- 21st, 2017 Iasi hosted hundreds of doctors and pharmacists specializing in...
The School Orchard project now includes two more schools
On Saturday, October 21st, 2017, over 50 Antibiotice employees volunteered to plant fruit tr...
Antibiotice – partner at the 13th Annual Meeting of the Euro-Asian Bridge Society for Cardiovascular Surgery
Antibiotice was a scientific partner at the Congress of the Euro-Asian Bridge Society for Cardio...
Nystatin – a bet made at the New York Stock Exchange and won at Iași
It all started 20 years ago with a bet made at the New York Stock Exchange. The challenge sou...
Antibiotice Iași imposes worlwide the quality standard for Nystatin
In 2017 Antibiotice Iasi obtained the title of international reference standard, for the active ...
Profit and sales income exceeded targets on 1st semester 2017
Net profit is up by 21% and sales revenue is 7% higher Antibiotice aimed at reaching the indica...
The 8th edition of Summer School a+
Practice mingles with theory, science and well-prepared people Already a tradition of our com...
Perform a+, a successful program
In July 2017, the Peform a + program ended. The nine participants (students and intern pharmacis...
The power of the deed is in our power!
Antibiotice employees support 52 students with dropout risk Antibiotice supports education w...
Play, joy, music and creation on the Children’s Day to Antibiotice
Antibiotice already has a tradition to offer a gift of June 1, to all its employees’children. Th...
Plant an orchard at school – an environmental awareness project
The Orchard at School (Livada de la Şcoala) is a project brought to 3 schools in Voroveşti, Pros...
Winners of the contest ”Be Pro-Nature! Put Soul!”
Winners of the contest ”Be Pro-Nature! Put Soul!” were nominated High emotions to the award c...
Antibiotice marks the World Environment Day
On Monday, May 29th, 60 students from Valea Lupului secondary school were invited by Antibiotice...
Primary school children visit Antibiotice
From 15th to 19th May, Antibiotice opened its gates to receive children from primary schools who...
Antibiotice at ”Made in Moldova” exbition
Made in Moldova Antibiotice participated with a presentation booth at the national pharmaceut...
The ideas of medical students awarded in the contest „The antibiotics – use them carefully! Everybody is responsible!”
The Antibiotice Company held on March 21 2017, in the Senate Hall of the "Gr. T. Popa "Universit...
The Antibiotice Company supports the campaign „End tuberculosis. Now and forever!”
In 2017 135 years are commemorated since the announcement made in 1882 by dr. Robert Koch about ...
Antibiotics were employees of Santa’s elves for 70 needy children
For the fourth consecutive year Antibiotics Foundation "Science and soul" organized campaign "Gi...
Waiting for Santa
Santa's elves have already prepared presents for the 70 children from orphanages in Iasi, where ...
Workshop for UMF Iaşi students on the responsible use of antibiotics
Thursday, on November 24, 2016, the Medical Students Society from the Grigore T. Popa Universi...
Antibiotics – use with care! Everyone is responsible!
Friday, November 18, 2016, on the occasion of the European Day of Awareness on Antibiotics, Anti...
Official visit of the President of Romania, Klaus Iohannis, to Antibiotice
Tuesday, on November 22, 2016, the President of Romania, Klaus Iohannis, visited Antibiotice SA....
Antibiotice Iaşi – Performanţă recunoscută în business-ul românesc
Antibiotice’s performance in business gets acknowledged Antibiotice was awarded the "Nationa...
Antibiotice “Strongest in Romania” 2
Antibiotice has obtained the certificate "Strongest in Romania” 2016 granted by CreditInfo. This...
Net profit up 22% and sales revenues up 5% in the third quarter of 2016
Results recorded by the company at the end of the first 9 months of 2016 show an increase in bot...
Antibiotice sales increased by 9% during the first quarter 2016 and the gross profit by 13%
According to the financial results communicated to the BSE, the value of the sales revenues achi...
Antibiotice attended CPhI 2016
Antibiotice Iași – 14 years of presence at the most important event in the global pharmaceutical...
Antibiotice initiates the 7th edition of Summer School a+
A well-established project by now, Antibiotice’s Summer School a+ opened its doors on July 14th,...
Major delivery of products for injection in the US market
Luna iunie a acestui an s-a incheiat cu o livrare record de produse injectabile pentru piata Sta...
Perform a+ project dedicated to the pharmacy students came to an end
In early June the first phase of the Perform a+ project was developed, aiming to attract new emp...
Gross profit up 21% in the first three months of 2016
In the first three months of 2016 the financial-economic results of our company fall within the ...
3% increase in sales revenues in 2015
Main decisions taken by Antibiotice’s General Meeting of Shareholders held on April 19, 2016 ...
Antibiotice – increases above the Romanian pharmaceutical market in 2015
Although for the first time in the recent years, the total market recorded a decrease both in va...
Antibiotice participated in the environmental awareness campaign – Earth Hour
For the eighth consecutive year, Antibiotice participated in the environmental awareness campaig...
Eveniment aniversar – 60 de ani de continuitate si performanta romaneasca
In December 2015 Antibiotice celebrated 60 years of activity on the pharmaceutical market. ...
The Antibiotice Company’s employees were Santa’s little helpers for 34 needy children
Today, December 23rd 2015, in a festive atmosphere, 34 needy children were visited by Santa's li...
Antibiotice, 60 years of Romanian continuity and performance
Antibiotice, the most prominent Romanian manufacturer of generic drugs celebrated this December ...
Antibiotice reports a 19% higher net profit than estimated
The sales revenue reported by Antibiotice in the first 9 months of 2015 amounted to 216.3 millio...
Antibiotice joined the European campaign promoting a correct use of antibiotics
On November 19th Antibiotice joined the campaign raising awareness on the proper use of antibiot...
Antibiotice – the First Prize in the National Top of Companies
Antibiotice has climbed this year also on the podium of the Top National Companies Gala, 22nd Ed...
Antibiotice achieved its forecasted profit target for the first half of 2015
The revenues from sales of the Antibiotice Company during the first half of the year 2015 amount...
Award for Business Excellence
Within the 2015 Excellence Gala organized by the City Hall of Iasi in partnership with the Metro...
Attending the CpHI 2015, Madrid, a growth engine of our international business
On 10-16 October 2015, our company is present at the most important event in the global pharmace...
60 years of sustained high Romanian performance!
Nowadays, Antibiotice is one of the key drug manufacturers in Romania. Every year new drugs from...
Antibiotics expands its businesses in Serbia
Antibiotice continues to expand its presence on the international markets. Starting with May 201...
24% increase in gross profit over the first 9 months of 2014
The results recorded by Antibiotice at the end of the first nine months of 2014 show an increase...
Antibiotice participated in the environmental awareness campaign – Earth Hour
For the eighth consecutive year, Antibiotice participated in the environmental awareness campaig...
Net profit goes up 15% in the first 3 months 2015
Today, May 15th, 2015, Antibiotice sent to the Bucharest Stock Exchange the financial results re...
Trophy for the most dynamic producer – exporter in Romania
Friday, December 14th, 2012, the pharmaceutical company Antibiotice was designated "the most dyn...
The elderly patient: an approach with science and soul
Recognized professionals in the medical environment, officials of the Iasi authorities in the he...
Antibiotice, along with the world largest producers in the pharmaceutical industry
For three days, between 9th and 12th of October, Antibiotice participated in CPhI Worldwide, th...
Antibiotice obtained the first prize in the National Top of Companies
For the fourth consecutive year, Antibiotice SA is awarded first prize on national level, under ...
7% growth in turnover and profit in the first nine months
The pharmaceutical company Antibiotice SA Iasi (symbol: ATB, listed on the first tier of the BSE...
57 years of knowledge and dedication
Day after day, those more than 150 medicines we produce reach over to the pharmacies and hospita...
Antibiotice is decorated for outstanding performance
In December 2013, Antibiotice was awarded the highest official distinction that can be offered t...
Antibiotice will increase the export value to the US market
The beginning of 2013 augurs well for Antibiotice. A few days ago, the company’s representatives...
Honoring life: Antibiotice employees donated blood on World Health Day
On the occasion of the World Health Day, on April 8, 2013, under the motto ”Donate blood, save a...
200 students visited Antibiotice within the week “To know more, to be better!”
More than 200 gymnasium and high-school students visited Antibiotice in the week 1-6 April, havi...
Antibiotice organizes the fourth edition of Summer School a+
The final year students and alumni of the Faculties of Medicine and Pharmacy, Chemistry, Chemic...
A new Antibiotice representative office in Chisinau
Antibiotice opened a new representative office in the Republic of Moldova in July. This decision...
Leader in Top of Iasi Companies
In October 2013, Antibioitice was awarded first prize in the twentieth edition of the Top of Iaş...
Antibiotice promptly answered the call to save lives!
For the second time this year, on Tuesday, September 24, Antibiotice’s employees donated blood t...
Antibiotice rewarded at the “Capital Awards” Gala
On Wednesday, May 27 the Capital Magazine organized in Bucharest the “Capital Awards” Gala, an e...
Antibiotice is awarded gold medals at EUROINVENT 2015
Within EUROINVENT 2015, the largest exhibition of inventions, projects and research in south-eas...
Antibiotice opened its gates to more than 500 students
Within the “School done differently” project, Antibiotice was visited by over 500 primary school...
Antibiotice employees donate blood
For the fifth consecutive year, Antibiotice employees donated blood on in order to prevent the a...
Antibiotice Science and Soul Foundation offered relief to underprivileged families
During the Easter holidays, the "Antibiotice Science and Soul" foundation helped 12 families in ...
Antibiotice shares went up 5.5% since early 2015
Antibiotice stock reported a 5.5% rise since the beginning of the current year. The increase ...
Antibiotice is awarded for its export performance
Antibiotice received the Trophy and the Diploma of Honour at the ANEIR Gala held in Bucharest, o...
At Antibiotice, Santa Claus offered gifts to 62 underprivileged children
On the 17th December, sixty-two children met Santa Claus at the headquarters of Antibiotice comp...
Back on the podium of the national companies
The System of the Chambers of Commerce and Industry of Romania awarded, on Thursday, November 6,...
Antibiotice gains new business prospects by participating in CPhI Paris
For the twelfth consecutive year, Antibiotice attended the world’s leading networking event in t...
At the National Congress of Pharmacy, Antibiotice welcomes pharmacists from all over Romania
On the occasion of the National Congress of Pharmacy held in Iaşi, September 24th - 27th, Antibi...
Antibiotice receives 2 awards at the National Congress of Pharmacy
On the occasion of the National Congress of Pharmacy held in Iasi, 24-26 September, 2014, Antibi...
1st June, an event for the employees’ children
On the International Children’s Day Antibiotice opened its gates to 160 children with ages betwe...
Antibiotice is awarded first prize in the National Top of Companies
Antibiotice was once again acknowledged at a national level for its outstanding results. At t...
Antibiotice sales increased by 6% in H1 2014, while the gross profit rose by 19%
According to the financial results the amount of income from sales recorded in the first half wa...
